Accelerating healthcare progress by unlocking the strategic value of lab data.
In 2011, hc1 Insights™ (hc1) was created because our founder recognized that if labs could organize the vast amounts of powerful data they produce into actionable insights, they could be empowered to better manage operations, as well as personalize and advance care for all patients.
Now nearly 15 years later, hc1 is the leader in identifying insights and risk signals from complex laboratory data to optimize patient care, improve operations, reduce supply chain costs and generate profitable growth.
Over the years, our technology solutions have helped us forge a broad set of lab and health system partnerships. Their ability to unlock actionable, real-time insights to increase efficiency and reduce costs continues to be enhanced and expanded through updates and add-on solutions. We have also introduced technology to empower independent and health system laboratory leaders with the insights they need to guide appropriate test utilization, enabling them to take effective action to ensure the right tests for the right patients.
In 2022 hc1 began providing insights to the pharma industry by identifying signals in lab, EHR and claims data to match precise patient needs with optimal therapies by clinicians, driving precision diagnostics and patient outcomes.
Most recently, in 2024, hc1 acquired Accumen, a best-in-class healthcare performance consulting company. The acquisition positions hc1 as the only comprehensive solution for transforming diagnostic labs into strategic assets for health systems.
Together, hc1 and Accumen will accelerate healthcare progress by harnessing the power of lab data to generate insights that improve patient care, streamline operations and reduce costs, all while achieving healthy growth to enhance financial performance.
